Lee-may Chen


Gynecologic cancer surgeon

About me

Dr. Lee-may Chen, a specialist in cancers of the female reproductive system, is director of UCSF's gynecologic oncology division. She has a particular interest in surgical and medical management of ovarian cancer.

Chen's research focuses on early detection in women who are at high risk of developing gynecological cancer, as well as symptom management and decision making in the treatment of these cancers.

Chen earned her medical degree and completed a residency in obstetrics and gynecology at the University of Michigan. She completed a fellowship in gynecologic oncology at the Ronald Reagan UCLA Medical Center before joining UCSF Medical Center in 1999.

  • Education

    University of Michigan School of Medicine, 1992

  • Residencies

    University of Michigan Medical Center, Obstetrics and Gynecology, 1996

  • Fellowships

    UCLA and Cedar Sinai Medical Center, Gynecologic Oncology, 1999

  • Board Certifications

    Obstetrics and Gynecology, American Board of Obstetrics and Gynecology

    Hospice and Palliative Medicine, American Board of Obstetrics and Gynecology

  • Academic Title


  • Languages


Clinics I work with

Gynecologic Surgical Oncology Clinic

Bakar Precision Cancer Medicine Building

1825 Fourth St., Sixth Floor
San Francisco, CA 94158

My reviews


Overall Experience
275 Reviews
Explained things in a way that was easy to understand
275 Reviews
Did the doctor pay attention to your concerns
274 Reviews
Gave easy to understand instructions about taking care of health problems or concerns
268 Reviews
Knew the important information about your medical history
273 Reviews
The provider showed respect for what you had to say
274 Reviews
The provider spent enough time with me
271 Reviews
Decorative Caduceus

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovar...

The PFS comparison will be assessed at the second interim and final analyses using a logrank test stratified by country and residual disease status. Estimates for the letrozole/letrozole (L/L) vs paclitaxel/carboplatin/letrozole (...


Decorative Caduceus

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Parti...

An adverse event (AE) is any untoward medical occurrence that occurs in a participant or clinical investigation participant administered a pharmaceutical product, and which does not necessarily have to have a causal relationship w...


Decorative Caduceus

Ribociclib and Letrozole Treatment in Ovarian Cancer

Determine the response rate of patients receiving the combination of Ribociclib and Letrozole